
Mirrorlights: Autistic patients at high risk of Parkinson's disease: Study
autism spectrum disorder
People with autism could be at a higher risk of developing Parkinson's disease early in life, according to a large-scale study that showed similar underlying biological mechanisms of the conditions.Researchers from the Karolinska Institutet questioned a possible connection between the neuropsychiatric diagnosis of(ASD), which affects an individual's thought processes, behaviour, and interpersonal communication, and early-onset Parkinson's disease -- a condition that affects locomotion and movement.The results, published in JAMA Neurology, show that people with an autism diagnosis were four times more likely to develop Parkinson's disease than people without such a diagnosis.'This indicates that there can be shared biological drivers behind ASD and Parkinson's disease,' said Weiyao Yin, researcher at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.'One hypothesis is that the brain's dopamine system is affected in both cases, since the neurotransmitter dopamine plays an important part in social behavior and motion control,' Yin added.The study is based on registry data from over two million people born in Sweden between 1974 and 1999, who were followed from the ageof 20 up to the end of 2022.It is well-known that dopamine-producing neurons are degraded in Parkinson's disease.Previous studies have also shown that dopamine is possibly implicated in autism, but more research needs to be done to confirm this.'We hope that our results will eventually help to bring greater clarity to the underlying causes of both ASD and Parkinson's disease,' Yin said.Calling for more studies, the researchers urged healthcare services to keep people with ASD -- a vulnerable group with high co-morbidity and high use of psychotropics -- under long-term observation.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NDTV
a day ago
- NDTV
Sleeping Disorders May Signal Risk Of Parkinson's Disease, Dementia: Study
New Delhi: Sleeping disorders may act as an early indicator of neurodegenerative diseases like Parkinson's disease and Lewy body dementia (LBD) -- a type of dementia, according to a study. The study focused on patients with Rapid eye movement behaviour disorder -- a sleep disorder where individuals physically act out their dreams during the rapid eye movement (REM) stage of sleep. "Normally, when we're asleep and dreaming, our muscles are paralysed, but around age 50, some people become very agitated during sleep and start punching, kicking and screaming," said Shady Rahayel, a medical professor at Université de Montréal in Canada. Unlike sleepwalking, which occurs during slow-wave sleep, RBD occurs during rapid eye movement (REM) sleep, he added, and it affects people of middle age. In the study, published in the journal eBioMedicine, the researchers said that nearly 90 per cent of people with the disorder will go on to develop either Parkinson's disease or LBD. "RBD is an early warning sign that certain mechanisms in the brain are no longer working as they should," said the team. "The people with RBD who come to see us are in good health... but of those who subsequently develop a disease, half will have Parkinson's and the other half LBD." Rahayel explained that with LBD, the second most common form of dementia after Alzheimer's, "patients are no longer able to function in everyday life". In addition to dementia, "they will have Parkinson's-like symptoms, vivid visual hallucinations, fluctuating attention and other symptoms." For the study, the team used data from 1,276 MRI scans of people at risk of, or with, Parkinson's disease or LBD, and also of healthy people. Using machine learning and computational models, the researchers identified two trajectories of brain atrophy progression. LBD seems to be associated with brain atrophy that begins in the cortex and then spreads to the interior of the brain, while in Parkinson's the atrophy progresses from the interior to the exterior of the brain. The team next aims to investigate the factors that lead to this deterioration in the cortex, such as vascular lesions, the effects of drugs, and of lifestyle choices. "Now that we have identified these new progression patterns, our goal is to be able to determine from an MRI whether a person has one of them so that we can provide the best possible care," said Rahayel.


Time of India
2 days ago
- Time of India
Mirrorlights: Autistic patients at high risk of Parkinson's disease: Study
autism spectrum disorder People with autism could be at a higher risk of developing Parkinson's disease early in life, according to a large-scale study that showed similar underlying biological mechanisms of the from the Karolinska Institutet questioned a possible connection between the neuropsychiatric diagnosis of(ASD), which affects an individual's thought processes, behaviour, and interpersonal communication, and early-onset Parkinson's disease -- a condition that affects locomotion and results, published in JAMA Neurology, show that people with an autism diagnosis were four times more likely to develop Parkinson's disease than people without such a diagnosis.'This indicates that there can be shared biological drivers behind ASD and Parkinson's disease,' said Weiyao Yin, researcher at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.'One hypothesis is that the brain's dopamine system is affected in both cases, since the neurotransmitter dopamine plays an important part in social behavior and motion control,' Yin study is based on registry data from over two million people born in Sweden between 1974 and 1999, who were followed from the ageof 20 up to the end of is well-known that dopamine-producing neurons are degraded in Parkinson's studies have also shown that dopamine is possibly implicated in autism, but more research needs to be done to confirm this.'We hope that our results will eventually help to bring greater clarity to the underlying causes of both ASD and Parkinson's disease,' Yin for more studies, the researchers urged healthcare services to keep people with ASD -- a vulnerable group with high co-morbidity and high use of psychotropics -- under long-term observation.


Time of India
3 days ago
- Time of India
Infant with rare genetic disorder gets life saving treatment
Vadodara: An infant boy from Panchmahal district got a new lease of life after he was diagnosed with an extremely rare hormonal disorder. The child was suffering from Aldosterone Synthase Deficiency (ASD), specifically the Corticosterone Methyl Oxidase Type II (CMO II), which slows down growth. The baby was presented with symptoms of poor feeding, frequent vomiting and developmental delays when it was five months old. The weight of the baby was 5kg and was not increasing. After observing the baby for some time, the doctors advised the parents to get genetic testing done. The report came in when the boy was seven months old and revealed that he had ASD. The condition affects the body's ability to retain salt and maintain normal blood pressure. Dr Bhargav Patel, a paediatrician at MT Mirani Hospital, which is run by the Sad Vichar Parivar in Godhra, said tests initially showed electrolyte imbalance and low aldosterone levels, prompting further genetic testing. He added that the condition, caused by mutations in the CYP11B2 gene, is so rare that only a handful of cases have been reported worldwide. "In this infant, the Thr185Ile mutation was identified. It is the first such case reported not only in Gujarat but across India, marking a rare genetic discovery," said Patel. He added that the diagnosis was confirmed through Whole Exome Sequencing. Treatment was initiated with fludrocortisone and salt supplementation, which led to visible improvements in just a few weeks. The child will have to keep taking hormones orally for life. "His feeding improved, weight increased and developmental milestones that had stalled began progressing again," said Dr Patel. He emphasized the need for awareness and genetic testing for rare paediatric disorders.